NEPOR

EUIPO EUIPO 2015 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark NEPOR was filed as Word mark on 06/02/2015 at the European Union Intellectual Property Office.
It was registered as a trademark on 10/15/2015. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 8, 2024

Trademark form Word mark
File reference 014188312
Application date June 2, 2015
Publication date June 10, 2015
Entry date October 15, 2015
Expiration date June 2, 2025

Trademark owner

Kurfürsten-Anlage 21
69115 Heidelberg
DE

Trademark representatives

Prinzregentenstr. 68 81675 München DE

goods and services

5 Diagnostic kits comprised of medical diagnostic reagents, in particular reagents for testing, determining and/or analyzing the level of protein and/or RNA expression in a biological sample derived from an individual, in particular the level of EPH-B4 (ephrin receptor) and/or Ephrin A1 receptor expression in a sample derived from tumor tissue or bodily fluids; diagnostic assays for testing of cells, tissue or bodily fluids for use in patient stratification and disease detection, namely cancer; biological and medical preparations and articles, in particular reagents for use in diagnostic and clinical tests, diagnostic biomarker reagents for medical purposes, in particular for enabling treatment decisions in connection with cancer patients, in particular with the administration of erythropoietin; pharmaceuticals and therapeutics, in particular for use in precision medicine; none of the aforesaid being for veterinary purposes, for dealing with insects or vermin, not for being in relation to wound care
44 Medical testing for diagnostic or treatment purposes; molecular testing for medical purposes; consulting services in the field of diagnostic medical testing and precision medicine, in particular in relation with treatment decisions and the administration of cancer drugs; health care consulting in the field of cancer treatment; providing online information, via the internet and mobile applications, in the fields of genetic and molecular testing and cancer diagnosis and treatment; medical and pharmaceutical consulting services relating to patient specific medical treatment options, in particular cancer treatment options; medical consulting services relating to the treatment and diagnosis of individuals; providing pharmaceutical and medical information, in particular information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals, in particular in connection with the administration of erythropoietin; medical consulting services in the fields of patient treatment and treatment protocols, diagnostic molecular testing, drug safety, dosage assessment, in particular in the field of cancer treatment therapy for others; none of the aforesaid being for veterinary purposes, for dealing with insects or vermin, not for being in relation to wound care

Trademark history

Date Document number Area Entry
January 16, 2019 Change Representative, Published
January 16, 2019 Change Representative, Published
December 1, 2015 Transfer / Change of address, Published
June 10, 2015 Transfer / Change of address, Published

ID: 11014188312